TuisALM • BME
add
Almirall SA
Vorige sluiting
€11,98
Dagwisseling
€11,48 - €11,88
Jaarwisseling
€8,65 - €13,98
Markkapitalisasie
2,47 mjd EUR
Gemiddelde volume
168,48 k
P/V-verhouding
54,90
Dividend-opbrengs
1,55%
Primêre beurs
BME
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 288,93 m | 11,37% |
Bedryfskoste | 310,92 m | 18,32% |
Netto inkomste | 7,05 m | 139,36% |
Netto winsgrens | 2,44 | 114,04% |
Wins per aandeel | — | — |
EBITDA | 23,70 m | -24,84% |
Effektiewe belastingkoers | 24,54% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 338,82 m | -10,20% |
Totale bates | 2,34 mjd | -2,48% |
Totale aanspreeklikheid | 850,00 m | -6,42% |
Totale ekwiteit | 1,49 mjd | — |
Uitstaande aandele | 214,79 m | — |
Prys om te bespreek | 1,73 | — |
Opbrengs op bates | 0,61% | — |
Opbrengs op kapitaal | 0,78% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 7,05 m | 139,36% |
Kontant van bedrywe | 28,16 m | -48,49% |
Kontant van beleggings | -22,64 m | -40,25% |
Kontant van finansiering | -44,35 m | -867,52% |
Netto kontantverandering | -38,83 m | -214,39% |
Beskikbare kontantvloei | 5,64 m | 133,50% |
Meer oor
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Gestig
1944
Webwerf
Werknemers
2 108
